Genome-wide Screen of SARS-CoV-2 Identifies Hyper-potent siRNAs for Nasal Administration

Yaniv Erlich | Eleven Therapeutics

Presented by

Yaniv Erlich

CEO, Eleven Therapeutics

Writing the Future of Drug Discovery

RECORDED AT Writing the Future of Drug Discovery

COVERED IN THIS WEBINAR

How siRNAs could serve as a new type of prophylaxis for SARS-CoV-2

Development of a framework called Sens.AI to find hyper-potent RNAi triggers

Use of Sens.AI to screen >16,000 RNAi triggers against SARS-CoV-2, testing virtually every amenable site in the virus genome

Share your details to Watch the Webinar

Genes